New treatment options encourage a fresh approach to patients.
A Q&A with John Corboy, MD, FAAN and Patricia Coyle, MD, FAAN
A small Phase I trial sees success using patients’ own altered blood cells to fight immune responses in MS. Is this the future of MS therapy?
A Q&A with Roland Martin, MD
An examination of both the pathophysiology of the link between obesity and brain injury, and available strategies that may reverse it.
By Majid Fotuhi, MD, PhD and Brooke Lubinski
Treatment options for tremor range from pharmacotherapy to possibly deep brain stimulation.
By Nader Pouratian, MD, PhD
By David B. Mandell, JD, MBA, Carole C. Foos, CPA
The potentially confusing category of medical foods may present options for disease management.
By James E. Galvin, MD, MPH
An inhalable form of levodopa aims to assist during “off” periods
By Zac Haughn, Senior Associate Editor
Watch the video at PracticalNeurology.net.
By Aziz Shaibani, MD
Phase IV data for fingolimod show high levels of patient satisfaction with oral therapy over injectables.